Search results
Here is What to Know Beyond Why Hims & Hers Health, Inc. (HIMS) is a Trending Stock
Zacks via Yahoo Finance· 4 days agoRecently, Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes...
Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know
Zacks· 6 days agoThe most recent trading session ended with Hims & Hers Health, Inc. (HIMS Quick QuoteHIMS - Free Report) standing at $24.15, reflecting a +1.68% shift from ...
3 Reasons to Buy Hims & Hers Health Stock Now
247wallst.com· 3 days agoAmong them, Hims & Hers Health (NYSE: HIMS), a telehealth and wellness platform, is down over 11% on the day to approximately $22 per share on higher...
Hims & Hers Health (NYSE:HIMS) Shares Up 2.8%
ETF DAILY NEWS· 4 days agoHims & Hers Health, Inc. (NYSE:HIMS – Get Free Report)’s share price shot up 2.8% during mid-day trading on Monday . The stock traded as high as $25.50 ...
Hims & Hers Health, Inc. (NYSE:HIMS) Insider Irene Becklund Sells 472 Shares of Stock
ETF DAILY NEWS· 4 days agoHims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) insider Irene Becklund sold 472 shares of the stock in a transaction that occurred on Monday, June ...
Insider Sale: Chief Commercial Officer Michael Chi Sells Shares of Hims & Hers Health Inc (HIMS)
GuruFocus.com via Yahoo Finance· 4 days agoChief Commercial Officer Michael Chi executed a sale of 25,549 shares of Hims & Hers Health Inc...
Market Whales and Their Recent Bets on HIMS Options - Hims & Hers Health (NYSE:HIMS)
Benzinga· 5 days agoLoading... Loading... High-rolling investors have positioned themselves bullish on Hims & Hers Health HIMS , and it's important for retail traders to take ...
Gateway - Quartz
Quartz· 5 days agoThe millennial-skewed telehealth platform Hims & Hers announced Monday that is now offering customers a compounded version of semaglutide, the active ingredient in popular ...
Is Acrivon Therapeutics, Inc. (ACRV) Stock Outpacing Its Medical Peers This Year?
Zacks via Yahoo Finance· 2 days agoThis means that Acrivon Therapeutics, Inc. is performing better than its sector in terms of...
Boston Scientific (BSX) to Buy Silk Road, Boost Cardiology
Zacks via Yahoo Finance· 4 days agoZacks Rank and Other Key Picks Boston Scientific carries a Zacks Rank #2 (Buy) currently. Some other...
